Reversing dopaminergic sensitization

The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

(2016) Raul Martínez-Fernández et al.   MOVEMENT DISORDERS

Parkinsonism–hyperpyrexia syndrome and deep brain stimulation

(2015) Carlo Alberto Artusi et al.   JOURNAL OF NEUROLOGY

Uncoupling of dopaminergic and subthalamic stimulation: Life-threatening DBS withdrawal syndrome

(2015) Sigrid Reuter et al.   MOVEMENT DISORDERS

Parkinsonism Hyperpyrexia Syndrome following Deep Brain Stimulation

(2015) Shyla T. Govindappa et al.   PARKINSONISM & RELATED DISORDERS

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

(2015) Matthieu F. Bastide et al.   PROGRESS IN NEUROBIOLOGY

L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2–Expressing Projection Neurons in Dyskinetic Mice

(2013) Luz M. Suárez et al.   BIOLOGICAL PSYCHIATRY

Drug-Evoked Synaptic Plasticity Causing Addictive Behavior

(2013) C. Luscher   JOURNAL OF NEUROSCIENCE

Malignant deep brain stimulation-withdrawal syndrome in a patient with Parkinson's disease

(2013) Janina Neuneier et al.   MOVEMENT DISORDERS

What is the role of the D3 receptor in addiction? A mini review of PET studies with [11C]-(+)-PHNO

(2013) Doris Payer et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Psychostimulant effect of levodopa: reversing sensitisation is possible

(2012) Anna Castrioto et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease

(2011) Anna Castrioto   ARCHIVES OF NEUROLOGY

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

(2011) S. S. O'Sullivan et al.   BRAIN

Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour

(2011) Vincent Pascoli et al.   NATURE

Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease

(2011) Véronique Sgambato-Faure et al.   PROGRESS IN NEUROBIOLOGY

Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation

(2011) Mario Gustavo Murer et al.   Frontiers in Neuroanatomy

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap

(2010) Paolo Calabresi et al.   LANCET NEUROLOGY

Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA–Induced Dyskinesia and Histone Activation

(2009) Sanja Darmopil et al.   BIOLOGICAL PSYCHIATRY

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

(2009) T. D. L. Steeves et al.   BRAIN

Prolonged Withdrawal from Repeated Noncontingent Cocaine Exposure Increases NMDA Receptor Expression and ERK Activity in the Nucleus Accumbens

(2009) J. Schumann et al.   JOURNAL OF NEUROSCIENCE

Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia

(2009) E. Santini et al.   Science Signaling

Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson's disease

(2008) A H Evans et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

(2008) Mariese A. Hely et al.   MOVEMENT DISORDERS